Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-09-28

Clinical Trial Update: Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

View source ↗

Summary

A clinical trial investigating whether expression of Th9 cells is associated with poor or non-response to Hepatitis B vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Municipal Science & Technology Commission | Conditions: Hepatitis B | Status: UNKNOWN